Plasmid construction: choosing the assembly route by what the construct becomes

There is no best cloning method, only a method that suits the number of parts, the sequence constraints and whether the construct is a one off or a template for a series. Choosing badly costs weeks of screening colonies that were never going to be right. This page maps the common routes onto the jobs they are good at, and says plainly where buying the construct beats building it.

good laboratory practice for nonclinical studies, 21 CFR
Part 58
the biosafety manual that decides containment for recombinant work
BMBL
electronic records and signatures, the clause behind a construct record
Part 11

The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a cloning price index it has not measured.

Choosing and running the build

  1. Count the parts and the reuse. One insert into one vector is a job for any method. Four or more parts, or a series of constructs sharing a part library, is where a standardised assembly with defined junctions repays the setup. If you will build this family again, build the library once.
  2. Check the sequence for the method's blind spots. Type two restriction assembly needs the chosen site absent from every part, and a single internal occurrence silently ruins the design. Overlap methods dislike repeats and strong secondary structure. Screen the sequence against the method before ordering anything.
  3. Design mutagenesis around template removal. Amplification based mutagenesis produces a mixture of new product and methylated parental template, and the digestion that removes the parental plasmid is the whole game. Skipping or under running it produces colonies that sequence as the original, which is the most common wasted week in this area.
  4. Match the ligase to the substrate. Standard double stranded ligation, single stranded ligation and adaptor joining are different enzymes with different buffers and different optimal temperatures. Using a general purpose enzyme on a specialist substrate produces a low yield that is usually blamed on the insert.
  5. Sequence the whole construct, not the junctions. Junction sequencing was a reasonable economy when reads were expensive. Whole plasmid sequencing now costs little and catches backbone rearrangements, unintended point changes and the wrong parent entirely, all of which junction reads miss.
  6. Decide build against buy honestly. A synthesised, sequence verified construct delivered ready to use frequently costs less than the labour of building it, particularly for difficult sequences or when a catalogue clone already exists. Price the bench time before defending the build.

Where each method earns its place, from golden gate assembly outwards

Restriction and ligation remains the clearest route for a single insert into a well characterised vector, and it is easy to teach and to troubleshoot. Overlap based assembly removes the site constraint and suits two or three parts with designed junctions. Type two site assembly comes into its own when the same parts recombine into many constructs, because the junctions become a standard rather than a design decision each time.

The cost of choosing wrongly is not the reaction, it is the colony screening. A method mismatched to the construct produces a low fraction of correct clones, and that is where the time goes.

Sequence verification is part of the build

A construct is not finished when a colony grows. It is finished when its full sequence is known and recorded against an identifier that the laboratory will still recognise in two years. That record should hold the sequence, the parent, the method, the date and the person, and it should live somewhere other than a laptop.

Groups that maintain this discipline rebuild their constructs rarely. Groups that do not rebuild them constantly, usually because nobody can prove what a tube contains.

What to ask a plasmid cloning service

What is delivered: plasmid at what quantity and purity, in which strain, with what sequence evidence, and whether the raw reads come with it. Who owns the construct and any intermediate. What happens if the sequence proves unbuildable, which for repeat rich or extreme composition sequences is a real outcome.

Also ask what happens next time. A service that keeps your part library and can rebuild variants quickly is worth more than a marginally cheaper one that starts from nothing each order.

The host decides the vector

An expression vector needs a promoter the host reads, a selection marker the host is sensitive to, an origin the host replicates and, where the protein is secreted, a signal the host processes. A vector built for one host will not express in another, however good the insert is.

Where a construct has to move between hosts, a vector carrying origins and markers for both saves rebuilding it. That is what a shuttle vector is, and its cost is a larger plasmid with more sequence to verify.

Integrating rather than persisting

A plasmid delivered to a mammalian cell is lost as the cells divide unless it integrates or is maintained. A transposase system integrates the cassette efficiently at many sites; an integrase system places it at a smaller number of preferred sites.

Integration site matters: many sites give higher aggregate expression and more variability between clones, while a defined site gives consistency and lower yield. Deciding which the experiment needs, before the construct is built, saves a round of cloning.

Build it, buy it, or have it synthesised

Traditional cloning is cheap in reagents and expensive in time, and it is the right route when a laboratory has the parts and the skill. Ordering the sequence as synthetic DNA removes the cloning entirely and has become cheap enough that building a routine construct by hand is often the more expensive option.

A construction service sits between the two: you specify the plasmid and receive it sequence-verified. Compare on the verified deliverable and the turnaround rather than on the price per base, and always ask what sequencing evidence comes with it.

Verifying what you actually have

A construct is not finished until its sequence is confirmed, and confirming only the insert leaves the junctions, the promoter and the backbone unverified. Whole-plasmid sequencing has become cheap enough that there is little reason to do less.

Keep the sequence file, the map and the verification with the glycerol stock, and record which clone number was used in each experiment. Most of the time lost to cloning is spent rediscovering what a tube in the freezer actually contains.

plasmid library construction, and what the diversity costs

A library is a construction problem with a counting problem attached. Diversity is introduced by degenerate oligonucleotides, error-prone amplification or synthesis of a designed set, and then it has to survive assembly and transformation: the number of independent clones recovered, not the theoretical diversity, is the library. That means high efficiency electrocompetent cells, enough transformations to cover the design several times over, and a sequencing check on the distribution before selection. Skewed representation is the usual failure, and it is invisible until a screen returns the same few members.

Plasmid design software, and what it has to get right

Design software earns its place on the tedious correctness: translating a sequence in the right frame, finding and avoiding restriction sites, designing primers with matched melting temperatures, simulating an assembly before anyone orders oligonucleotides, and keeping a versioned record of what was designed against what was sequenced. The features that matter after that are collaboration and annotation, because a construct's map is institutional memory, and export, since a design locked in one vendor's format is a liability. Free and paid tools both do the core well; the record-keeping is what differs.

Common questions

Which assembly method should a laboratory standardise on?
Whichever matches its most common job. Groups building multipart constructs repeatedly benefit from a standardised type two site assembly with a maintained part library; groups making occasional single insert constructs rarely need more than overlap assembly or ordering the construct.
Why do my site directed mutagenesis reactions give the original sequence?
Almost always incomplete removal of the methylated parental template. Check the enzyme is active, extend the digestion and confirm that the input plasmid came from a strain that methylates, because template from a methylation deficient strain will not be cut at all.
Is whole plasmid sequencing worth it every time?
Yes, for anything that will be used more than once or shared. The cost is small against the cost of discovering a backbone rearrangement after six months of experiments built on the construct.
When does an off the shelf ORF clone beat a custom build?
Whenever the sequence, the tag position and the vector backbone you need already exist in a catalogue. The saving is not only the build but the sequence verification and the risk, and the main thing to check is the exact isoform and the licence attached to it.
Should I clone it or have it synthesised?
Synthesis has become cheap enough that building a routine construct by hand is often more expensive once time is counted. Clone by hand where you already have the parts and the skill; buy a sequence-verified construct where turnaround matters.
How much of a plasmid should I sequence?
All of it. Verifying only the insert leaves junctions, promoter and backbone unchecked, and whole-plasmid sequencing is now cheap enough that there is little reason to do less.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/plasmid-construction/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices